BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37963252)

  • 1. Invasion-Block and S-MARVEL: A high-content screening and image analysis platform identifies ATM kinase as a modulator of melanoma invasion and metastasis.
    Guo D; Jurek R; Beaumont KA; Sharp DS; Tan SY; Mariana A; Failes TW; Grootveld AK; Bhattacharyya ND; Phan TG; Arndt GM; Jain R; Weninger W; Tikoo S
    Proc Natl Acad Sci U S A; 2023 Nov; 120(47):e2303978120. PubMed ID: 37963252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a cell-based, high-throughput screening assay for ATM kinase inhibitors.
    Guo K; Shelat AA; Guy RK; Kastan MB
    J Biomol Screen; 2014 Apr; 19(4):538-46. PubMed ID: 24464432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of ATM and ATR to the resistance of glioblastoma and malignant melanoma cells to the methylating anticancer drug temozolomide.
    Eich M; Roos WP; Nikolova T; Kaina B
    Mol Cancer Ther; 2013 Nov; 12(11):2529-40. PubMed ID: 23960094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of ataxia telangiectasia mutated kinase activity enhances TRAIL-mediated apoptosis in human melanoma cells.
    Ivanov VN; Zhou H; Partridge MA; Hei TK
    Cancer Res; 2009 Apr; 69(8):3510-9. PubMed ID: 19351839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serine-Threonine Kinase TAO3-Mediated Trafficking of Endosomes Containing the Invadopodia Scaffold TKS5α Promotes Cancer Invasion and Tumor Growth.
    Iizuka S; Quintavalle M; Navarro JC; Gribbin KP; Ardecky RJ; Abelman MM; Ma CT; Sergienko E; Zeng FY; Pass I; Thomas GV; McWeeney SK; Hassig CA; Pinkerton AB; Courtneidge SA
    Cancer Res; 2021 Mar; 81(6):1472-1485. PubMed ID: 33414172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensors and Inhibitors for the Detection of Ataxia Telangiectasia Mutated (ATM) Protein Kinase.
    Huang C; Filippone NR; Reiner T; Roberts S
    Mol Pharm; 2021 Jul; 18(7):2470-2481. PubMed ID: 34125542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Mechanism-Based Targeted Screen To Identify Epstein-Barr Virus-Directed Antiviral Agents.
    Li X; Akinyemi IA; You JK; Rezaei MA; Li C; McIntosh MT; Del Poeta M; Bhaduri-McIntosh S
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32796077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma.
    Pastorino L; Dalmasso B; Allavena E; Vanni I; Ugolini F; Baroni G; Croce M; Guadagno A; Cabiddu F; Andreotti V; Bruno W; Zoppoli G; Ferrando L; Tanda ET; Spagnolo F; Menin C; Gangemi R; Massi D; Ghiorzo P
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of chemotherapy with BRAF inhibitors results in effective eradication of malignant melanoma by preventing ATM-dependent DNA repair.
    Alonso-Marañón J; Villanueva A; Piulats JM; Martínez-Iniesta M; Solé L; Martín-Liberal J; Segura S; Pujol RM; Iglesias M; Bigas A; Gallardo F; Espinosa L
    Oncogene; 2021 Aug; 40(31):5042-5048. PubMed ID: 34140639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells.
    Jette NR; Radhamani S; Arthur G; Ye R; Goutam S; Bolyos A; Petersen LF; Bose P; Bebb DG; Lees-Miller SP
    Br J Cancer; 2019 Oct; 121(7):600-610. PubMed ID: 31481733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of novel ataxia telangiectasia mutated (ATM) kinase modulators: Computational simulation, biological evaluation and cancer combinational chemotherapy study.
    Dou X; Sun X; Huang H; Jiang L; Jin Z; Liu Y; Zou Y; Li Z; Zhu G; Jin H; Jiao N; Zhang L; Liu Z; Zhang L
    Eur J Med Chem; 2022 Apr; 233():114196. PubMed ID: 35231830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenformin and ataxia-telangiectasia mutated inhibitors synergistically co-suppress liver cancer cell growth by damaging mitochondria.
    Wu T; Zhou S; Qin M; Tang J; Yan X; Huang L; Huang M; Deng J; Xiao D; Hu X; Wu J; Yang X; Li G
    FEBS Open Bio; 2021 May; 11(5):1440-1451. PubMed ID: 33742560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ATM pathway.
    Yin Y; Xu L; Chang Y; Zeng T; Chen X; Wang A; Groth J; Foo WC; Liang C; Hu H; Huang J
    Mol Cancer; 2019 Jan; 18(1):11. PubMed ID: 30657058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATM-Mediated Phosphorylation of Cortactin Involved in Actin Polymerization Promotes Breast Cancer Cells Migration and Invasion.
    Lang L; Hou Y; Chen Y; Tu G; Tao J; Yang D; Xi L; Fu L; Sun K; Yin J; Chen R; Peng M; Liu S; Liu M
    Cell Physiol Biochem; 2018; 51(6):2972-2988. PubMed ID: 30562756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antiproliferative effects of ataxia-telangiectasia mutated and ATM- and Rad3-related inhibitions and their enhancements with the cytotoxicity of DNA damaging agents in cholangiocarcinoma cells.
    Moolmuang B; Ruchirawat M
    J Pharm Pharmacol; 2021 Mar; 73(1):40-51. PubMed ID: 33791808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-Wide Screening in Human Embryonic Stem Cells Highlights the Hippo Signaling Pathway as Granting Synthetic Viability in ATM Deficiency.
    Viner-Breuer R; Golan-Lev T; Benvenisty N; Goldberg M
    Cells; 2023 May; 12(11):. PubMed ID: 37296624
    [No Abstract]   [Full Text] [Related]  

  • 17. An HTRF
    Adams P; Clark J; Hawdon S; Hill J; Plater A
    Methods Mol Biol; 2017; 1599():43-56. PubMed ID: 28477110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ataxia-telangiectasia mutated activation mediates tumor necrosis factor-alpha induced MMP-13 up-regulation and metastasis in lung cancer cells.
    Yan HQ; Zhang D; Shi YY; You X; Shi L; Li Q; Gao FG
    Oncotarget; 2016 Sep; 7(38):62070-62083. PubMed ID: 27556690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of the Transcriptional Disease Signature (TDSs) to Screen Melanoma-Effective Compounds in a Small Fish Model.
    Lu Y; Boswell W; Boswell M; Klotz B; Kneitz S; Regneri J; Savage M; Mendoza C; Postlethwait J; Warren WC; Schartl M; Walter RB
    Sci Rep; 2019 Jan; 9(1):530. PubMed ID: 30679619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The versatile functions of ATM kinase.
    Boohaker RJ; Xu B
    Biomed J; 2014; 37(1):3-9. PubMed ID: 24667671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.